CSPC Pharmaceutical Group's total assets for Q4 2025 were HK$52.01B, an increase of 13.07% from the previous quarter. HK:1093 total liabilities were HK$13.53B for the fiscal quarter, a 21.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.